ERVW-1 and viral infectious disease: Based on our pilot experiment, around 20:1 weight ratio (total 3 μg) of pcHFV-EF1a-EGFP and pCMV-optEnv resulted in the most effective viral infection efficacy, likely due to the more stable expression of optEnv compared to the original Env (Fig. 2C).